Perrigo Complete Buy Of Rosemont Pharmaceuticals For $283 Million
ALLEGAN - Perrigo Company announced that it has signed a definitive merger agreement and has completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately $283 million in cash. Founded in 1967, Rosemont is a specialty and generic prescription pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations. Rosemont's current portfolio